ev3 Initiates Voluntary Recall of Specific Lots of NanoCross™ .014" OTW PTA Dilatation Catheter
Contacts:
Rachel Bloom Baglin
Vice President, Communications
Vascular Therapies
508-261-6651
rachel.bloombaglin@covidien.com
Bruce Farmer
Vice President
Public Relations
508-452-4372
bruce.farmer@covidien.com
Cole Lannum, CFA
Vice President
Investor Relations
508-452-4343
cole.lannum@covidien.com
FOR IMMEDIATE RELEASE – Plymouth, MN – December 15, 2010 - ev3, a Covidien company, has initiated a voluntary recall of specific lots of the NanoCross™ .014" OTW PTA Dilatation Catheter due to the potential for the catheter shaft to crack or break during use. Cracking or breaking of the catheter shaft may result in the inability to inflate or deflate the balloon, and may result in material separation and potential embolization. The device failure may lead to unplanned intravascular or open surgery, significant vasospasm, prolonged tissue ischemia, tissue, injury, infarct, bleeding and/or death. The Food and Drug Administration (FDA) has classified the recall as a Class I recall. FDA classifies a recall as Class I when the agency believes there is a reasonable probability that the use of the recalled product will cause serious adverse health consequences or death.
The NanoCross 0.014" OTW PTA Dilatation Catheter is intended to dilate stenosis in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The NanoCross Dilatation Catheter is not an implant. It is removed and discarded after the procedure is completed.
The voluntary recall affects certain lots of the NanoCross .014" OTW PTA Dilatation Catheters manufactured between May 27, 2010, and October 18, 2010. Only the NanoCross .014" OTW PTA Dilatation Catheters from lot numbers listed below is affected by this action. All affected healthcare facilities have been notified of this action in a letter dated November 10, 2010. Healthcare facilities should take immediate action to locate and remove from use the specified NanoCross PTA Dilatation Catheters. Detailed steps were provided in the Customer Notification letter for return and disposition of affected products.
Affected ev3 NanoCross™ .014" OTW PTA Dilatation Catheter Product Catalog / Lot Numbers
Cat. # AB14W020040150
Lot Numbers:
8631564
8664386
8703047
8743036
8745610
8749903
8784866
8792531
8821432
8837969
8847440
8871669
9209927
Cat. # AB14W020080150
Lot Numbers:
8672990
8710423
8778807
8778808
8789928
8811586
8837970
9153521
9222820
Cat. # AB14W020120150
Lot Numbers:
8672994
8755401
8755602
8755604
8784858
8795999
8810475
9023725
9050028
9074214
9088260
9146365
9198871
9209680
9235823
9248597
9254604
9266768
Cat. # AB14W020150150
Lot Numbers:
8746781
8784859
8798136
8827211
8851945
8964937
Cat. # AB14W020210150
Lot Numbers:
8778745
8778748
8778749
8789891
8810468
8821428
9097151
9195071
9214883
9216811
9221177
9231361
9238413
Cat. # AB14W025040150
Lot Numbers:
8746902
8746903
8749908
8784864
8810470
8826743
8846663
8915544
8985597
9235612
Cat. # AB14W025080150
Lot Numbers:
8664384
8711789
8741778
8778813
8796007
8821434
8846664
9218102
9232283
Cat. # AB14W025120150
Lot Numbers:
8722274
8722275
8722277
8741791
8745616
8815365
8815410
9013770
9023719
9082516
9097149
9178997
9222934
9254886
9270248
Cat. # AB14W025150150
Lot Numbers:
8789931
8810473
8827208
8854221
8877645
8989919
9237414
Cat. # AB14W025210150
Lot Numbers:
8744140
8757219
8826331
8826333
8826336
9082532
9155514
9180316
9209447
9222907
9233059
9238795
Cat. # AB14W030040150
Lot Numbers:
8630847
8703042
8703044
8703050
8737491
8741794
8755622
8789946
8796008
8841532
8842327
8847442
8871667
8916474
8985601
9217289
9221183
Cat. # AB14W030080150
Lot Numbers:
8674379
8710383
8745612
8757468
8795994
8816902
8838736
9153523
9203512
9221180
9232658
9237412
Cat. # AB14W030120150
Lot Numbers:
8711873
8741781
8755603
8784854
8792133
8810472
9023729
9062683
9097148
9179000
9224585
9231360
9248574
9254782
9286411
Cat.# AB14W030150150
Lot Numbers:
8741786
8749899
8789924
8810474
8836819
8871664
8970944
Cat.# AB14W030210150
Lot Numbers:
8815676
8816203
8816467
8821338
8821419
8836748
8847435
9083740
9148256
9194250
9216747
9221182
9235807
9263491
Cat.# AB14W035040150
Lot Numbers:
8705822
8784860
8853567
8989918
Cat.# AB14W035080150
Lot Numbers:
8757061
8815414
9078466
9248425
Cat.# AB14W035120150
Lot Numbers:
8703049
8815409
9078464
9208441
9286249
Cat.# AB14W035150150
Lot Numbers:
8822758
Cat.# AB14W035210150
Lot Numbers:
8789883
8828189
9208439
9221817
Cat.# AB14W040040150
Lot Numbers:
8629968
8657024
8755600
8755601
8755625
8789935
8821431
8842537
8877650
8970943
9209903
Cat.# AB14W040080090
Lot Numbers:
9220075
9225648
Cat.# AB14W040080150
Lot Numbers:
8722279
8749882
8787509
8822999
9216848
9224246
9237413
Cat.# AB14W040120150
Lot Numbers:
8738444
8749895
8778810
8789939
8822880
9000723
9018516
9097147
9194251
9204433
9248553
9263037
9283623
Cat.# AB14W040210150
Lot Numbers:
8741777
8751214
8784853
8810467
8822411
8836749
9235780
9245449
Cat.# AB14W040150150
Lot Numbers:
8747184
8796001
8837761
8873813
The lot numbers for all NanoCross .014” OTW PTA Dilatation catheters are clearly printed on the front and sides of the product packaging.
Healthcare professionals and customers may report adverse events or quality problems experienced with the use of this product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or by phone.
- Online: www.fda.gov/medwatch/report.htm
- Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm.
Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787 - Fax: 1-800-332-0178
- Phone: 1-800-332-1088
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
